TELO
Telomir Pharmaceuticals, Inc.
0.5950
+0.02 (+2.73%)
52w low 0.5450
1.58 high
4.8% of range
Financial Analysis
| (USD) | Mar 25 | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Trend |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -- | -696.45K | -927.26K | -1.20M | -1.77M | -1.01M | |
| Free Cash Flow | -- | -696.45K | -927.26K | -1.20M | -1.77M | -1.01M | |
| Financing Cash Flow | -- | 1.05M | 7.50M | 1.16M | 47.35K | 622.11K |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--